Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Liver Cirrhosis

Free Subscription 20.05.2024 2 BMC Gastroenterol 1 Dig Dis Sci 5 Hepatology 8 J Hepatol 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Gastroenterol

1. ZHANG Q, Yu T, Tan H, Shi H, et al
   Hepatic recruitment of myeloid-derived suppressor cells upon liver injury promotes both liver regeneration and fibrosis.
   BMC Gastroenterol. 2024;24:163.
   PubMed         Abstract available
   
   
2. GUO Y, Dong S, Li M, Tao Y, et al
   A new model of portal vein thrombosis in rats with cirrhosis induced by partial portal vein ligation plus carbon tetrachloride and intervened with rivaroxaban.
   BMC Gastroenterol. 2024;24:161.
   PubMed         Abstract available
   
   

   
   Dig Dis Sci

3. ARSHAD T, Vainer D, Khan H, Baral A, et al
   Development of Clinical Algorithm Utilizing Vibration-Controlled Transient Elastography to Detect Advanced Hepatic Fibrosis in Liver Transplant Recipients.
   Dig Dis Sci. 2024 Mar 18. doi: 10.1007/s10620-024-08366.
   PubMed         Abstract available
   
   

   
   Hepatology

4. LOMBARDI R, Dalbeni A, Mantovani A, Ravaioli F, et al
   Reply: AGILE 3+ score, enhancing the diagnostic accuracy of advanced fibrosis in patients with nonalcoholic fatty liver disease.
   Hepatology. 2024;79:E155-E156.
   PubMed        
   
   
5. CALZADILLA-BERTOT L, Jeffrey AW, Jeffrey GP
   Letter to the Editor: AGILE 3+ score, enhancing the diagnostic accuracy of advanced fibrosis in patients with nonalcoholic fatty liver disease.
   Hepatology. 2024;79:E153-E154.
   PubMed        
   
   
6. LEE CM, Yoon EL, Kim M, Kang BK, et al
   Prevalence, distribution and hepatic fibrosis burden of the different subtypes of steatotic liver disease in primary care settings.
   Hepatology. 2023 Nov 1. doi: 10.1097/HEP.0000000000000664.
   PubMed         Abstract available
   
   
7. ENGSTROM A, Wintzell V, Melbye M, Svanstrom H, et al
   Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 diabetes: A Scandinavian cohort study.
   Hepatology. 2024;79:1401-1411.
   PubMed         Abstract available
   
   
8. WANG A, Blackford AL, Behling C, Wilson LA, et al
   Development of Fibro-PeN, a clinical prediction model for moderate-to-severe fibrosis in children with nonalcoholic fatty liver disease.
   Hepatology. 2024;79:1381-1392.
   PubMed         Abstract available
   
   

   
   J Hepatol

9. KRUK B, Liebe R, Weber SN, Milkiewicz P, et al
   ARID3A variant and the risk of primary biliary cholangitis in a Central European cohort.
   J Hepatol. 2023 Nov 28:S0168-8278(23)05290-X. doi: 10.1016/j.jhep.2023.
   PubMed        
   
   
10. TANG R, Li Y, Chen R, Ma X, et al
    Reply to "ARID3A variant and the risk of primary biliary cholangitis in a Central European cohort".
    J Hepatol. 2024 Jan 30:S0168-8278(24)00058-8. doi: 10.1016/j.jhep.2024.
    PubMed        
    
    
11. XU M, Warner C, Duan X, Cheng Z, et al
    HIV coinfection exacerbates HBV-induced liver fibrogenesis through a HIF-1alpha- and TGF-beta1-dependent pathway.
    J Hepatol. 2024;80:868-881.
    PubMed         Abstract available
    
    
12. WARGNY M, Goronflot T, Rimbert A, Boursier J, et al
    Primary hypocholesterolemia is associated with an increased risk of hepatic complications in the general population.
    J Hepatol. 2024 Feb 6:S0168-8278(24)00108-9. doi: 10.1016/j.jhep.2024.
    PubMed         Abstract available
    
    
13. WU XN, Wang MZ, Zhang N, Zhang W, et al
    Sex-determining region Y gene promotes liver fibrosis and accounts for sexual dimorphism in its pathophysiology.
    J Hepatol. 2024;80:928-940.
    PubMed         Abstract available
    
    
14. DAI H, Zhu C, Huai Q, Xu W, et al
    Chimeric antigen receptor-modified macrophages ameliorate liver fibrosis in preclinical models.
    J Hepatol. 2024;80:913-927.
    PubMed         Abstract available
    
    
15. CAON E, Martins M, Hodgetts H, Blanken L, et al
    Exploring the impact of the PNPLA3 I148M variant on primary human hepatic stellate cells using 3D extracellular matrix models.
    J Hepatol. 2024 Feb 14:S0168-8278(24)00110-7. doi: 10.1016/j.jhep.2024.
    PubMed         Abstract available
    
    
16. YANG M, Zhang F, Liu K
    Cirrhosis Decompensation: Clinical and Prognostic Analysis from a New Perspective.
    J Hepatol. 2024 May 9:S0168-8278(24)00337-4. doi: 10.1016/j.jhep.2024.
    PubMed        
    
    

    
    PLoS One

17. OSAWA Y, Kawai H, Nakashima K, Nakaseko Y, et al
    Sphingosine-1-phosphate promotes liver fibrosis in metabolic dysfunction-associated steatohepatitis.
    PLoS One. 2024;19:e0303296.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge.